4: Statement of changes in beneficial ownership of securities-Director Aryeh Jason
May 2 18:10 ET
4: Statement of changes in beneficial ownership of securities-Director KOZARICH JOHN W
Apr 26 18:39 ET
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Davis Todd C
Mar 27 17:50 ET
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sabba Stephen L
Mar 7 13:30 ET
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Aryeh Jason
Mar 6 17:31 ET
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Reardon Andrew
Feb 29 18:54 ET
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Korenberg Matthew E
Feb 29 18:54 ET
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Espinoza Octavio
Feb 29 18:54 ET
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Davis Todd C
Feb 29 18:54 ET
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Reardon Andrew
Feb 16 20:12 ET
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Korenberg Matthew E
Feb 16 20:12 ET
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Espinoza Octavio
Feb 16 20:12 ET
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Davis Todd C
Feb 16 20:12 ET
Ligand Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Macquarie Group Limited(5.66%),Macquarie Management Holdings Inc(5.66%), etc.
Feb 14 06:31 ET
Ligand Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(10.76%)
Feb 13 17:50 ET
Ligand Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(7.7%),Janus Henderson Triton Fund(5.1%)
Feb 13 15:41 ET
Ligand Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-THE GOLDMAN SACHS GROUP, INC.(6.8 %),GOLDMAN SACHS & CO. LLC(6.8 %)
Feb 12 19:45 ET
Ligand Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(17.0%)
Jan 22 00:00 ET
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Reardon Andrew
Jan 4 00:00 ET
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Espinoza Octavio
Dec 6, 2023 15:27 ET
No Data
No Data